Influence of CCR5 and CCR2 Genetic Variants in the Resistance/Susceptibility to HIV in Serodiscordant Couples from Colombia

Abstract

The main genetic factor related to HIV-1 resistance is the CCR5-Δ32 mutation; however, the homozygous genotype is uncommon. The CCR5-Δ32 mutation along with single nucleotide polymorphisms (SNPs) in the CCR5 promoter and the CCR2-V64I mutation have been included in seven human haplogroups (HH) previously associated with resistance/susceptibility to HIV-1 infection and different rates of AIDS progression. Here, we determined the association of the CCR5 promoter SNPs, the CCR5-Δ32 mutation, CCR2-V64I SNP, and HH frequencies with resistance/susceptibility to HIV-1 infection in a cohort of HIV-1-serodiscordant couples from Colombia. Seventy HIV-1-exposed, but seronegative (HESN) individuals, 57 seropositives (SP), and 112 healthy controls (HC) were included. The CCR5-Δ32 mutation and CCR2-V64I SNP were identified by PCR, and the CCR5 promoter SNPs were evaluated by sequencing. None of the individuals exhibited a homozygous Δ32 genotype; the CCR2-I allele was more frequent in HESN (34%) than HC (23%) (p=0.039, OR=1.672). The frequency of the 29G allele was higher in SP than HC (p=0.003, OR=3). HHF2 showed a higher frequency in HC (19%) than SP (9%) (p=0.027), while HHG1 was more frequent in SP (11.1%) than in HC (4.2%) (p=0.019). The AGACCAC-CCR2-I-CCR5 wild-type haplotype showed a higher frequency in SP (14.2%) than in HC (3.7%) (p=0.001). In conclusion, the CCR5-Δ32 allele is not responsible for HIV-1 resistance in this HESN group; however, the CCR2-I allele could be protective, while the 29G allele might increase the likelihood of acquiring HIV-1 infection. HHG1 and the AGACCAC-CCR2-I-CCR5 wild-type haplotype might promote HIV-1 infection while HHF2 might be related to resistance. However, additional studies are required to evaluate the implications of these findings.

Get full access to this article

View all access options for this article.

References

UNAIDS: Global report: UNAIDS report on the global AIDS epidemic 2010.

Piacentini

, Biasin

, Fenizia

et al. Genetic correlates of protection against HIV infection: The ally within. J Intern Med, 2009; 265,1:110–124.

Piacentini

, Fenizia

, Naddeo

et al. Not just sheer luck! Immune correlates of protection against HIV-1 infection. Vaccine, 2008; 26,24:3002–3007.

Singh

, Kaur

, Sharma

et al. Immunogenetic basis of HIV-1 infection, transmission and disease progression. Vaccine, 2008; 26,24:2966–2980.

Kulkarni

, Butera

, Duerr

. Resistance to HIV-1 infection: Lessons learned from studies of highly exposed persistently seronegative (HEPS) individuals. AIDS Rev, 2003; 5,2:87–103.

Hugonnet

, Mosha

, Todd

et al. Incidence of HIV infection in stable sexual partnerships: A retrospective cohort study of 1802 couples in Mwanza Region, Tanzania. J Acquir Immune Defic Syndr, 2002; 30,1:73–80.

Liu

, Paxton

, Choe

et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell, 1996; 86,3:367–377.

Rana

, Besson

, Cook

et al. Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: Resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation. J Virol, 1997; 71,4:3219–3227.

Jang

, Choi

, Kim

. The effects of RANTES/CCR5 promoter polymorphisms on HIV disease progression in HIV-infected Koreans. Int J Immunogenet, 2008; 35,2:101–105.

10.

Mummidi

, Bamshad

, Ahuja

et al. Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus. J Biol Chem, 2000; 275,25:18946–18961.

11.

Tang

, Shelton

, Makhatadze

et al. Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression. J Virol, 2002; 76,2:662–672.

12.

Hladik

, Liu

, Speelmon

et al. Combined effect of CCR5-delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission. J Virol, 2005; 79,18:11677–11684.

13.

Knudsen

, Kristiansen

, Katzenstein

et al. Adverse effect of the CCR5 promoter -2459A allele on HIV-1 disease progression. J Med Virol, 2001; 65,3:441–444.

14.

Pedersen

, Kamwendo

, Blood

et al. CCR5 haplotypes and mother-to-child HIV transmission in Malawi. PLoS One, 2007; 2,9:e838.

15.

Lee

, Doranz

, Rana

et al. Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4. J Virol, 1998; 72,9:7450–7458.

16.

Singh

, Barroga

, Hughes

et al. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection. J Infect Dis, 2003; 188,10:1461–1472.

17.

Ometto

, Zanchetta

, Mainardi

et al. Co-receptor usage of HIV-1 primary isolates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission. AIDS, 2000; 14,12:1721–1729.

18.

Gonzalez

, Bamshad

, Sato

et al. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci USA, 1999; 96,21:12004–12009.

19.

Excoffier

, Laval

, Schneider

. Arlequin (version 3.0): An integrated software package for population genetics data analysis. Evol Bioinform Online, 2005; 1:47–50.

20.

Nguyen

, Li

, Chaowanachan

et al. CCR5 promoter human haplogroups associated with HIV-1 disease progression in Thai injection drug users. AIDS, 2004; 18,9:1327–1333.

21.

Zapata

, Rodriguez

, Weber

et al. Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individuals. Curr HIV Res, 2008; 6,6:531–538.

22.

Diaz

, Vega

, Patino

et al. Frequency of CCR5 delta-32 mutation in human immunodeficiency virus (HIV)-seropositive and HIV-exposed seronegative individuals and in general population of Medellin, Colombia. Mem Inst Oswaldo Cruz, 2000; 95,2:237–242.

23.

Hersberger

, Marti-Jaun

, Hanseler

et al. Rapid detection of the CCR2-V64I, CCR5-A59029G and SDF1-G801A polymorphisms by tetra-primer PCR. Clin Biochem, 2002; 35,5:399–403.

24.

Barrett

, Fry

, Maller

et al. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics, 2005; 21,2:263–265.

25.

Purcell

, Todd-Brown

, Thomas

et al. PLINK: A toolset for whole-genome association, population-based linkage analysis. Am J Hum Genet, 2007; 81,3:559–575.

26.

Rugeles

, Solano

, Diaz

et al.

Molecular characterization of the CCR 5 gene in seronegative individuals exposed to human immunodeficiency virus (HIV)

J Clin Virol, 2002; 23,3:161–169.

27.

Huang

, Paxton

, Wolinsky

et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med, 1996; 2,11:1240–1243.

28.

, Jessen

, Kucherer

et al. CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individual. PLoS One, 2008; 3,7:e2747.

29.

Sheppard

, Celum

, Michael

et al. HIV-1 infection in individuals with the CCR5-delta32/delta32 genotype: Acquisition of syncytium-inducing virus at seroconversion. J Acquir Immune Defic Syndr, 2002; 29,3:307–313.

30.

Smith

, Dean

, Carrington

et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science, 1997; 277,5328:959–965.

31.

Kaur

, Singh

, Rapthap

et al. Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians. Hum Immunol, 2007; 68,5:454–461.

32.

Kostrikis

, Neumann

, Thomson

et al. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J Virol, 1999; 73,12:10264–10271.

33.

Salkowitz

, Bruse

, Meyerson

et al. CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro. Clin Immunol, 2003; 108,3:234–240.

34.

, Qiao

, Zhang

et al. A haplotype in the CCR5 gene promoter was associated with the susceptibility to HIV-1 infection in a northern Chinese population. Mol Biol Rep, 2011; 38,1:327–332.

35.

Bedoya

, Montoya

, Garcia

et al. Admixture dynamics in Hispanics: A shift in the nuclear genetic ancestry of a South American population isolate. Proc Natl Acad Sci USA, 2006; 103,19:7234–7239.

36.

Rojas

, Parra

, Campo

et al. Genetic make up and structure of Colombian populations by means of uniparental and biparental DNA markers. Am J Phys Anthropol, 2010; 143,1:13–20.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.02 MB

0.03 MB

0.02 MB

0.00 MB